• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡博替尼相关骨坏死在骨扫描中进展,类似转移。

Progression of Cabozantinib-Related Osteonecrosis Mimicking Metastases on Bone Scan.

机构信息

From the Division of Diagnostic Imaging, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

Clin Nucl Med. 2021 Jul 1;46(7):592-594. doi: 10.1097/RLU.0000000000003522.

DOI:10.1097/RLU.0000000000003522
PMID:33577198
Abstract

Patient was a 73-year-old woman with metastatic renal cell carcinoma. Bone scan showed multifocal bone metastases. The patient received cabozantinib treatment for more than 1 year. On the follow-up bone scan, the previously biopsy-proven left pelvic bone lesion has improved, whereas the right maxillary lesion showed increased extent and intensity of abnormal radiotracer uptake. Given the different change pattern of these lesions, the right maxillary lesion was further evaluated. Biopsy results confirmed devitalized bone with bacterial colonies overgrowth and without tumor cell, suggestive of medication-related osteonecrosis.

摘要

患者为 73 岁女性,患有转移性肾细胞癌。骨扫描显示多处骨转移。该患者接受卡博替尼治疗超过 1 年。在后续的骨扫描中,之前经活检证实的左侧骨盆骨病变有所改善,而右侧上颌骨病变的范围和异常放射性示踪剂摄取的强度增加。鉴于这些病变的变化模式不同,对右侧上颌骨病变进行了进一步评估。活检结果证实骨失活,有细菌菌落过度生长,无肿瘤细胞,提示与药物相关的骨坏死。

相似文献

1
Progression of Cabozantinib-Related Osteonecrosis Mimicking Metastases on Bone Scan.卡博替尼相关骨坏死在骨扫描中进展,类似转移。
Clin Nucl Med. 2021 Jul 1;46(7):592-594. doi: 10.1097/RLU.0000000000003522.
2
Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic.卡博替尼治疗转移性肾细胞癌——来自捷克共和国四个肿瘤中心的最终数据分析。
Klin Onkol. 2021 Fall;34(5):392-400. doi: 10.48095/ccko2021392.
3
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.卡博替尼,晚期肾细胞癌和骨转移患者的新标准治疗?METEOR 试验的亚组分析。
J Clin Oncol. 2018 Mar 10;36(8):765-772. doi: 10.1200/JCO.2017.74.7352. Epub 2018 Jan 8.
4
In brief: Cabozantinib (Cabometyx) for advanced renal cell carcinoma.简而言之:卡博替尼(Cabometyx)用于晚期肾细胞癌。
Med Lett Drugs Ther. 2016 Jul 18;58(1499):e97.
5
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer.卡博替尼在骨转移性肾细胞癌和去势抵抗性前列腺癌中的生物学问题。
Future Oncol. 2018 Oct;14(25):2559-2564. doi: 10.2217/fon-2018-0158. Epub 2018 Aug 24.
6
Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.卡博替尼在肾细胞癌放射性耐药脑转移瘤中的活性:两例报告
J Med Case Rep. 2018 Nov 25;12(1):351. doi: 10.1186/s13256-018-1875-9.
7
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma.卡博替尼相关气胸在肾细胞癌快速缓解患者中的情况
Lancet Oncol. 2019 Feb;20(2):e124. doi: 10.1016/S1470-2045(18)30577-1.
8
Hand-foot skin reaction with primarily dorsal involvement in a patient with metastatic renal cell carcinoma on cabozantinib.一名接受卡博替尼治疗的转移性肾细胞癌患者出现主要累及背部的手足皮肤反应。
Dermatol Online J. 2020 Aug 15;26(8):13030/qt1v33j40c.
9
Response to cabozantinib in renal cell carcinoma with cardiac metastases.卡博替尼治疗伴心脏转移的肾细胞癌的疗效。
Anticancer Drugs. 2020 Mar;31(3):314-318. doi: 10.1097/CAD.0000000000000889.
10
Cutaneous leucocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma.卡博替尼治疗肾细胞癌继发的皮肤白细胞破碎性血管炎。
Clin Exp Dermatol. 2021 Jun;46(4):739-740. doi: 10.1111/ced.14541. Epub 2021 Jan 10.

引用本文的文献

1
Unusual Diffuse and Heterogeneous FDG Uptake in Appendicular Bone Marrow Space in a Patient with Acute Lymphoblastic Leukemia.一名急性淋巴细胞白血病患者的四肢骨髓腔内出现异常弥漫性及不均匀的氟代脱氧葡萄糖摄取。
Indian J Nucl Med. 2023 Jul-Sep;38(3):303-304. doi: 10.4103/ijnm.ijnm_3_23. Epub 2023 Oct 10.